Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinfeng Pill for Polycystic Ovary Syndrome
NCT06823830Phase 4Active, not recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Jinfeng Pill in polycystic ovary syndrome (PCOS), sponsored by Peking Union Medical College Hospital. Started Sep 2023; status: active, not recruiting.
02
Drugs
Jinfeng Pill
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06823830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06823830.